StockWatch
·
Residential- Commercial Projects
Tax & Penalty28 Jul 2026, 09:10 pm

Max Estates Subsidiary Receives ₹5.9 Cr GST Show Cause Notice

AI Summary

Max Estates Limited's subsidiary, Pharmax Corporation Limited, has received a show cause notice from the Department of Trade and Taxes, Government of NCT of Delhi, for FY 2022-23. The notice, issued under GST laws, proposes a demand of ₹5,90,00,108, primarily related to alleged excess or ineligible input tax credit. The subsidiary is reviewing the notice and will file a reply. No final order has been passed, and the financial impact is contingent on adjudication proceedings. Operations of the company and its subsidiary remain unaffected at this stage.

Key Highlights

  • Subsidiary Pharmax Corporation received GST show cause notice.
  • Proposed demand aggregates to ₹5.9 Cr for FY 2022-23.
  • Notice relates to alleged excess/ineligible input tax credit.
  • No final order passed; financial impact is uncertain.
  • Operations remain unaffected; company will update stakeholders.